Evidence map›Paper›PMID 33723250›Full record

ArticleNature communications2021

Branched-chain α-ketoacids are preferentially reaminated and activate protein synthesis in the heart.

Jacquelyn M Walejko, Bridgette A Christopher, Scott B Crown, Guo-Fang Zhang, Adrian Pickar-Oliver, Takeshi Yoneshiro, Matthew W Foster, Stephani Page, Stephan van Vliet, Olga Ilkayeva and 11 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 1 pooled it
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 1 synthesis or guideline pooled it, 92 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Biocompatible SABRE Hyperpolarization of [1-Chemistry (Weinheim an der Bergstrasse, Germany) · 2026
    Article
  5. Dynamic [Research square · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. BCAA Metabolic Dyshomeostasis in Cardiovascular Disease: Pathogenic Mechanisms and Intervention.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2026
    Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 2 institutions in 1 country.

Jacquelyn M Walejko *Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, NC, USA.
Bridgette A Christopher *Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, NC, USA.
Scott B Crown *Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, NC, USA.ORCID 0000-0002-1983-2101
Guo-Fang ZhangDuke Molecular Physiology Institute, Duke University School of Medicine, Durham, NC, USA.
Adrian Pickar-OliverDepartment of Biomedical Engineering, Duke University, Durham, NC, USA.
Takeshi YoneshiroUCSF Diabetes Center, San Francisco, CA, USA.
Matthew W FosterDuke Proteomics and Metabolomics Shared Resource, Duke University School of Medicine, Durham, NC, USA.ORCID 0000-0003-0212-2346
Stephani PageDuke Molecular Physiology Institute, Duke University School of Medicine, Durham, NC, USA.
Stephan van VlietDuke Molecular Physiology Institute, Duke University School of Medicine, Durham, NC, USA.ORCID 0000-0001-8992-555X
Olga IlkayevaDuke Molecular Physiology Institute, Duke University School of Medicine, Durham, NC, USA.ORCID 0000-0002-9779-0883
Michael J MuehlbauerDuke Molecular Physiology Institute, Duke University School of Medicine, Durham, NC, USA.
Matthew W CarsonEli Lilly and Company, Indianapolis, IN, US.
Joseph T BrozinickEli Lilly and Company, Indianapolis, IN, US.
Craig D HammondEli Lilly and Company, Indianapolis, IN, US.
Ruth E GimenoEli Lilly and Company, Indianapolis, IN, US.
M Arthur MoseleyDuke Proteomics and Metabolomics Shared Resource, Duke University School of Medicine, Durham, NC, USA.
Shingo KajimuraUCSF Diabetes Center, San Francisco, CA, USA.ORCID 0000-0003-0672-5910
Charles A GersbachDepartment of Biomedical Engineering, Duke University, Durham, NC, USA.ORCID 0000-0003-1478-4013
Christopher B NewgardDuke Molecular Physiology Institute, Duke University School of Medicine, Durham, NC, USA.ORCID 0000-0002-1293-691X
Phillip J WhiteDuke Molecular Physiology Institute, Duke University School of Medicine, Durham, NC, USA. phillip.white@duke.edu.ORCID 0000-0002-0957-425X
Robert W McGarrahDuke Molecular Physiology Institute, Duke University School of Medicine, Durham, NC, USA. robert.mcgarrah@duke.edu.ORCID 0000-0001-6693-7152
Duke University · USEli Lilly (United States) · US

Funding

ZIDOVUDINE &LAMIVUDINE &NEVIRAPINE COMBINATION THERAPY IN HIV 1 INFM01RR001271 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KESSLER, DAVID A · 1985 to 2006
$22.7M
Research BaseP30DK063720 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VAISSE, CHRISTIAN · 2003 to 2019
$21.8M
UCSF Nutrition Obesity Research CenterP30DK098722 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHRISTIAN VAISSE · 2015 to 2026
$14.6M
National Metabolomics Data Repository - nextgen Metabolomics WorkbenchU2CDK119886 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SUBRAMANIAM, SHANKAR · 2018 to 2021
$12.7M
Pilot & Feasibility ProgramP30DK124723 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI P Darrell Neufer · 2020 to 2026
$11.0M
MULTIDISCIPLINARY HEART &VASCULAR DISEASEST32HL007101 · NHLBI · DUKE UNIVERSITY · PI FREEDMAN, NEIL J. · 1985 to 2020
$9.8M
Molecular mechanisms of UCP1-independent pathways in metabolic healthR01DK097441 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Shingo Kajimura · 2012 to 2026
$5.9M
Mitochondrial Metabolite Compartmentalization in Health and DiseaseDP1DK126160 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI KAJIMURA, SHINGO · 2020 to 2025
$4.4M
Mitochondrial BCAA transporter in physiology and diseaseR01DK125283 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI KAJIMURA, SHINGO · 2021 to 2025
$1.8M
CRISPR/Cas9-Based Gene Editing for the Correction of Duchenne Muscular DystrophyR01AR069085 · NIAMS · DUKE UNIVERSITY · PI GERSBACH, CHARLES A. · 2016 to 2020
$1.7M
The Branched Chain Ketoacid Dehydrogenase Kinase-Phosphatase System as a New Regulatory Node in Mycocardial Fuel SectionK08HL135275 · NHLBI · DUKE UNIVERSITY · PI MCGARRAH, ROBERT WALKER · 2018 to 2022
$713k
13C-Metabolic Flux Analysis for Understanding Cardiac Energy HomeostasisF32HL137398 · NHLBI · DUKE UNIVERSITY · PI CROWN, SCOTT B. · 2017 to 2019
$155k
NCRR NIH HHS M01 RR001271NHLBI NIH HHS F32 HL137398NHLBI NIH HHS K08 HL135275NHLBI NIH HHS L30 HL124508NHLBI NIH HHS T32 HL007101NIAMS NIH HHS R01 AR069085NIDDK NIH HHS DP1 DK126160NIDDK NIH HHS P30 DK063720NIDDK NIH HHS P30 DK098722NIDDK NIH HHS P30 DK124723NIDDK NIH HHS R01 DK097441NIDDK NIH HHS R01 DK125283NIDDK NIH HHS U2C DK119886
6 · The paper itself

Abstract

Branched-chain amino acids (BCAA) and their cognate α-ketoacids (BCKA) are elevated in an array of cardiometabolic diseases. Here we demonstrate that the major metabolic fate of uniformly-

Indexed as

Amino Acids, Branched-ChainAnimalsHeartHemiterpenesKeto AcidsMaleMiceMice, Inbred C57BLMitochondriaObesityRatsValinealpha-ketoisovalerateAmino Acids, Branched-ChainHemiterpenesKeto AcidsValine

Identifiers

PMID33723250
PMCPMC7960706
OpenAlexW3138331545

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.